Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 11, 2020

Primary Completion Date

May 31, 2021

Study Completion Date

May 31, 2021

Conditions
Persistent Asthma
Interventions
COMBINATION_PRODUCT

fluticasone/formoterol k-haler (medium strength)

2 inhalations every 12 hours

COMBINATION_PRODUCT

Standard of care (ICs/LABA high strength)

Depend of the ICs/LABA combination

Sponsors
All Listed Sponsors
collaborator

Alpha Bioresearch S.L.

OTHER

collaborator

Dynamic Solutions

INDUSTRY

lead

Mundipharma Pharmaceuticals S.L.

INDUSTRY